A Multicenter, Open Label, Dose Finding Study to Evaluate Efficacy and Safety of Givinostat Administered in Two Different Doses in Patients With Poly JIA Not Adequately Responding to the Standard Treatment.
Latest Information Update: 08 Nov 2021
At a glance
- Drugs Givinostat (Primary)
- Indications Juvenile rheumatoid arthritis
- Focus Therapeutic Use
- Sponsors Italfarmaco
Most Recent Events
- 21 Jun 2012 Additional location added as reported by ClinicalTrials.gov.
- 21 Jun 2012 Additional location added as reported by ClinicalTrials.gov.
- 21 Jun 2012 Actual patient number is 16 according to ClinicalTrials.gov.